מיפורטיק 360 מ"ג इसराइल - हिब्रू - Ministry of Health

מיפורטיק 360 מ"ג

novartis pharma services ag - mycophenolic acid 360 mg - film coated tablets - mycophenolic acid - myfortic is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in adult patients receiving allogeneic renal transplants.

ריספפר 1 מ"ג इसराइल - हिब्रू - Ministry of Health

ריספפר 1 מ"ג

pharmalogic ltd - risperidone 1 mg - film coated tablets - risperidone - risperidone is indicated for the management of schizophrenia and manifestation of psychotic disorders. the antipsychotic efficacy of risperidone was established in short-term (6 to 8 weeks) controlled trials of schizophrenic inpatients. risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. risperidone is indicated for the treatment of psychotic manifestations of dementia. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment- requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years. risperidone is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated expansive or irritable mood inflated self-esteem decreased need for sleep pressured speech racing thoughts distract

ריספפר 2 מ"ג इसराइल - हिब्रू - Ministry of Health

ריספפר 2 מ"ג

pharmalogic ltd - risperidone 2 mg - film coated tablets - risperidone - risperidone is indicated for the management of schizophrenia and manifestation of psychotic disorders. the antipsychotic efficacy of risperidone was established in short-term (6 to 8 weeks) controlled trials of schizophrenic inpatients. risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. risperidone is indicated for the treatment of psychotic manifestations of dementia. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment- requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years. risperidone is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated expansive or irritable mood inflated self-esteem decreased need for sleep pressured speech racing thoughts distract

ריספפר 3 מ"ג इसराइल - हिब्रू - Ministry of Health

ריספפר 3 מ"ג

pharmalogic ltd - risperidone 3 mg - film coated tablets - risperidone - risperidone is indicated for the management of schizophrenia and manifestation of psychotic disorders. the antipsychotic efficacy of risperidone was established in short-term (6 to 8 weeks) controlled trials of schizophrenic inpatients. risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. risperidone is indicated for the treatment of psychotic manifestations of dementia. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment- requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years. risperidone is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated expansive or irritable mood inflated self-esteem decreased need for sleep pressured speech racing thoughts distract

ריספפר 4 מ"ג इसराइल - हिब्रू - Ministry of Health

ריספפר 4 מ"ג

pharmalogic ltd - risperidone 4 mg - film coated tablets - risperidone - risperidone is indicated for the management of schizophrenia and manifestation of psychotic disorders. the antipsychotic efficacy of risperidone was established in short-term (6 to 8 weeks) controlled trials of schizophrenic inpatients. risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. risperidone is indicated for the treatment of psychotic manifestations of dementia. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment- requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years. risperidone is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated expansive or irritable mood inflated self-esteem decreased need for sleep pressured speech racing thoughts distract

ואלאציקלוביר טבע ® 500 מ"ג इसराइल - हिब्रू - Ministry of Health

ואלאציקלוביר טבע ® 500 מ"ג

teva pharmaceutical indust.ltd - valaciclovir hydrochloride (as dihydrate) 500 mg - film coated tablets - valaciclovir - valaciclovir teva is indicated for the treatment of herpes zoster (shingles) in immunocompetent adults . valaciclovir teva accelerates the resolution of pain, it reduces the duration, and the proportion of patients with zoster-associated pain, which includes acute and post-herpetic neuralgia. the efficacy of valaciclovir teva in immunocompromised patients has not been established. - valaciclovir teva is indicated for the treatment of the initial and recurrent genital herpes due to herpes simplex infection. - valaciclovir is indicated for the prevention (suppression) of recurrent herpes simplex infections (herpes genitalis). - prophylaxis of cytomegalovirus infection and disease, following organ transplantation. - for the treatment of cold sores (herpes labialis).

רופינירול טבע ® 0.5 מ"ג इसराइल - हिब्रू - Ministry of Health

רופינירול טבע ® 0.5 מ"ג

teva pharmaceutical indust.ltd - ropinirole as hydrochloride 0.5 mg - film coated tablets - ropinirole - treatment of idiopathic parkinson's disease : ropinirole may be used alone in the treatment of idiopathic parkinson's disease.addition of ropinirole to levodopa may be used to control " on - off " fluctuations and permit a reduction in the total daily dose of levodopa.

רופינירול טבע ® 1 מ"ג इसराइल - हिब्रू - Ministry of Health

רופינירול טבע ® 1 מ"ג

teva pharmaceutical indust.ltd - ropinirole as hydrochloride 1 mg - film coated tablets - ropinirole - treatment of idiopathic parkinson's disease: ropinirole may be used alone in the treatment of idiopathic parkinson's disease.addition of ropinirole to levodopa may be used to control "on-off" fluctuations and permit a reduction in the total daily dose of levodopa.

רופינירול טבע ® 5 מ"ג इसराइल - हिब्रू - Ministry of Health

רופינירול טבע ® 5 מ"ג

teva pharmaceutical indust.ltd - ropinirole as hydrochloride 5 mg - film coated tablets - ropinirole - treatment of idiopathic parkinson's disease: ropinirole may be used alone in the treatment of idiopathic parkinson's disease.addition of ropinirole to levodopa may be used to control "on-off" fluctuations and permit a reduction in the total daily dose of levodopa.

טרקספין 300 इसराइल - हिब्रू - Ministry of Health

טרקספין 300

taro pharmaceutical industries ltd - oxcarbazepine 300 mg - film coated tablets - carboxamide derivatives - treatment of primary generalised tonic - clonic seizures and partial seizures with or without secondary generalization.